These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets. Belshe RB; Richardson LS; Prevar DA; Camargo E; Chanock RM Arch Virol; 1978; 58(4):313-21. PubMed ID: 736795 [TBL] [Abstract][Full Text] [Related]
5. Defective synthesis of envelope proteins by temperature-sensitive mutants representing complementation groups B and D of respiratory syncytial virus. Caravokyri C; Pringle CR J Gen Virol; 1991 Oct; 72 ( Pt 10)():2501-8. PubMed ID: 1919527 [TBL] [Abstract][Full Text] [Related]
6. Initiation and maintenance of persistent infection by respiratory syncytial virus. P'ringle CR; Shirodaria PV; Cash P; Chiswell DJ; Malloy P J Virol; 1978 Oct; 28(1):199-211. PubMed ID: 702647 [TBL] [Abstract][Full Text] [Related]
8. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Whitehead SS; Firestone CY; Collins PL; Murphy BR Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916 [TBL] [Abstract][Full Text] [Related]
9. Growth and genetic stability of the ts-1 mutant of respiratory syncytial virus at restrictive temperatures. Schnitzer TJ; Richardson LS; Chanock RM J Virol; 1976 Feb; 17(2):431-8. PubMed ID: 943572 [TBL] [Abstract][Full Text] [Related]
10. Genetic stability determinants of temperature sensitive, live attenuated respiratory syncytial virus vaccine candidates. Lin YH; Deatly AM; Chen W; Miller LZ; Lerch R; Sidhu MS; Udem SA; Randolph VB Virus Res; 2006 Jan; 115(1):9-15. PubMed ID: 16099066 [TBL] [Abstract][Full Text] [Related]
11. Antigen and polypeptide synthesis by temperature-sensitive mutants of respiratory syncytial virus. Pringle CR; Shirodaria PV; Gimenez HB; Levine S J Gen Virol; 1981 May; 54(Pt 1):173-83. PubMed ID: 7288405 [TBL] [Abstract][Full Text] [Related]
12. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Crowe JE; Bui PT; Davis AR; Chanock RM; Murphy BR Vaccine; 1994 Jul; 12(9):783-90. PubMed ID: 7975856 [TBL] [Abstract][Full Text] [Related]
13. Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures. Schickli JH; Kaur J; Tang RS Virus Res; 2012 Oct; 169(1):38-47. PubMed ID: 22771939 [TBL] [Abstract][Full Text] [Related]
14. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Crowe JE; Collins PL; London WT; Chanock RM; Murphy BR Vaccine; 1993 Nov; 11(14):1395-404. PubMed ID: 8310760 [TBL] [Abstract][Full Text] [Related]
15. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Crowe JE; Bui PT; London WT; Davis AR; Hung PP; Chanock RM; Murphy BR Vaccine; 1994 Jun; 12(8):691-9. PubMed ID: 8091846 [TBL] [Abstract][Full Text] [Related]
16. Assignment of mutant tsN19 (complementation group E) of respiratory syncytial virus to the P protein gene. Caravokyri C; Zajac AJ; Pringle CR J Gen Virol; 1992 Apr; 73 ( Pt 4)():865-73. PubMed ID: 1378878 [TBL] [Abstract][Full Text] [Related]
17. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Crowe JE; Bui PT; Siber GR; Elkins WR; Chanock RM; Murphy BR Vaccine; 1995 Jun; 13(9):847-55. PubMed ID: 7483808 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation. Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364 [TBL] [Abstract][Full Text] [Related]
19. Effect of temperature-sensitive mutation on activity of the RNA transcriptase of vesicular stomatitis virus New Jersey. Szilágyi JF; Pringle CR J Virol; 1979 Jun; 30(3):692-700. PubMed ID: 225538 [TBL] [Abstract][Full Text] [Related]
20. Pneumoviruses: the cell surface of lytically and persistently infected cells. Parry JE; Shirodaria PV; Pringle CR J Gen Virol; 1979 Aug; 44(2):479-91. PubMed ID: 118236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]